Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
3
×
biotech
boston blog main
life sciences
national blog main
alirocumab
amgen
boston top stories
clinical trials
deals
evolocumab
inclisiran
national top stories
new york
new york blog main
new york top stories
pcsk9 inhibitors
regeneron pharmaceuticals
rna interference
beijing
brii bio
brii biosciences
china
drugs
evercore isi
fda
glaxosmithkline
gsk
heart attack
hepatitis b
joseph swartz
medicines co.
novartis
pcsk9
raleigh-durham
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
sanofi
startups
What
drug
medicines
3
×
new
3
×
cholesterol
medco
acquire
adds
agreed
alliance
alnylam
areas
based
billion
biosciences
bio’s
brii
brings
cash
company
compound
data
deal
disease
earlier
evidence
fda
heart
hepatitis
infectious
lasting
launched
long
looms
lowering
million
mission
novartis
partner
pharmaceuticals
pipeline
Language
unset
Current search:
medicines
×
new
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline